Tomlinson S - Search Results

1

Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection.

Varela JC, Atkinson C, Woolson R, Keane TE, Tomlinson S. Varela JC, et al. Among authors: tomlinson s. Int J Cancer. 2008 Sep 15;123(6):1357-63. doi: 10.1002/ijc.23676. Int J Cancer. 2008. PMID: 18561323 Free PMC article.

2

Targeting of functional antibody-decay-accelerating factor fusion proteins to a cell surface.

Zhang H, Lu S, Morrison SL, Tomlinson S. Zhang H, et al. Among authors: tomlinson s. J Biol Chem. 2001 Jul 20;276(29):27290-5. doi: 10.1074/jbc.M100436200. Epub 2001 May 14. J Biol Chem. 2001. PMID: 11352906 Free article.

3

A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer.

Caragine TA, Okada N, Frey AB, Tomlinson S. Caragine TA, et al. Among authors: tomlinson s. Cancer Res. 2002 Feb 15;62(4):1110-5. Cancer Res. 2002. PMID: 11861390

4

Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity.

Caragine TA, Imai M, Frey AB, Tomlinson S. Caragine TA, et al. Among authors: tomlinson s. Blood. 2002 Nov 1;100(9):3304-10. doi: 10.1182/blood.V100.9.3304. Blood. 2002. PMID: 12384431 Free article.

5

Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.

Song H, He C, Knaak C, Guthridge JM, Holers VM, Tomlinson S. Song H, et al. Among authors: tomlinson s. J Clin Invest. 2003 Jun;111(12):1875-85. doi: 10.1172/JCI17348. J Clin Invest. 2003. PMID: 12813023 Free PMC article.

6

The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo.

Imai M, Hwang HY, Norris JS, Tomlinson S. Imai M, et al. Among authors: tomlinson s. Immunology. 2004 Mar;111(3):291-7. doi: 10.1111/j.0019-2805.2004.01815.x. Immunology. 2004. PMID: 15009429 Free PMC article.

7

Inhibition of a complement regulator in vivo enhances antibody therapy in a model of mammary adenocarcinoma.

Imai M, Ohta R, Okada N, Tomlinson S. Imai M, et al. Among authors: tomlinson s. Int J Cancer. 2004 Jul 20;110(6):875-81. doi: 10.1002/ijc.20178. Int J Cancer. 2004. PMID: 15170670

8

Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.

Atkinson C, Song H, Lu B, Qiao F, Burns TA, Holers VM, Tsokos GC, Tomlinson S. Atkinson C, et al. Among authors: tomlinson s. J Clin Invest. 2005 Sep;115(9):2444-53. doi: 10.1172/JCI25208. Epub 2005 Aug 25. J Clin Invest. 2005. PMID: 16127466 Free PMC article.

9

Complement-mediated mechanisms in anti-GD2 monoclonal antibody therapy of murine metastatic cancer.

Imai M, Landen C, Ohta R, Cheung NK, Tomlinson S. Imai M, et al. Among authors: tomlinson s. Cancer Res. 2005 Nov 15;65(22):10562-8. doi: 10.1158/0008-5472.CAN-05-1894. Cancer Res. 2005. PMID: 16288049

10

Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.

Qiao F, Atkinson C, Song H, Pannu R, Singh I, Tomlinson S. Qiao F, et al. Among authors: tomlinson s. Am J Pathol. 2006 Sep;169(3):1039-47. doi: 10.2353/ajpath.2006.060248. Am J Pathol. 2006. PMID: 16936276 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters